Increased production of interleukin-2 (IL-2) but not soluble interleukin-2 receptors (sIL-2R) in unmedicated patients with schizophrenia and schizophreniform disorder.
This study investigated immune activation, as measured by production of interleukin-2 (IL-2) and soluble interleukin-2 receptors (sIL-2R) from stimulated lymphocytes, in schizophrenia and schizophreniform disorder. The study included 13 neuroleptic-free patients, 13 medicated patients and 13 age- and sex-matched control subjects. Production of IL-2 and sIL-2R by peripheral blood mononuclear cells (PBMCs) was measured after in vitro stimulation with phytohaemagglutinin (PHA). Patients' symptoms were rated on the Scales for Assessment of Positive (SAPS) and Negative Symptoms (SANS) and the Brief Psychiatric Rating Scale (BPRS). IL-2 production by stimulated lymphocytes was significantly elevated in neuroleptic-free patients compared with both medicated patients and control subjects. IL-2 production was inversely correlated with the SAPS subscales of bizarre behaviour and formal thought disorder. The pattern of increased IL-2 production is in contrast to previous findings in patients with schizophrenia. Significant associations with clinical rating scores suggest that IL-2 production may vary in different biological subgroups of schizophrenia and schizophreniform disorder.
O'Donnell
M C
MC
Department of Psychiatry, University of New South Wales, Sydney, Australia.
Catts
S V
SV
Ward
P B
PB
Liebert
B
B
Lloyd
A
A
Wakefield
D
D
McConaghy
N
N
D000328:Adult; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000097:blood*; D008213:Lymphocyte Activation / Q000276:immunology; D008297:Male; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000175:diagnosis / Q000276:immunology* / Q000523:psychology; D015375:Receptors, Interleukin-2 / Q000097:blood*; D012016:Reference Values; D012559:Schizophrenia / Q000145:classification / Q000175:diagnosis / Q000276:immunology*; D012565:Schizophrenic Psychology
D007376:Interleukin-2; D015375:Receptors, Interleukin-2